Register Login

Betrixaban (Bevyxxa) Approved June 23

The FDA approved Portola’s anti-Xa direct oral anticoagulant Betrixaban as Bevyxxa on June 23, 2017. Click or tap here for the FDA announcement and here for Portola’s press release, indications, and prescribing information. Thanks to Dr. Ali Sadeghi-Khomami of Precision BioLogic for sending along the announcement.

Comments (0)
Anticoagulant Therapy

No comments here.

Leave a Reply